Approved Symbol |
Approved Name |
Location |
Source |
PLK1 |
polo-like kinase 1 |
16p |
Mapped by significant region |
CDC26 |
cell division cycle 26 homolog (S. cerevisiae) |
9q32 |
Mapped by significant region |
ANAPC4 |
anaphase promoting complex subunit 4 |
4p15.31 |
Mapped by CNV |
E2F5 |
E2F transcription factor 5, p130-binding |
8q21.2 |
Mapped by CNV |
CDC14B |
CDC14 cell division cycle 14 homolog B (S. cerevisiae) |
9q22.3 |
Mapped by significant region |
YWHAQ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
2p25.2-p25.1 |
Mapped by significant region |
CHEK1 |
CHK1 checkpoint homolog (S. pombe) |
11q24.2 |
Mapped by significant region |
SKP2 |
S-phase kinase-associated protein 2 (p45) |
5p13 |
Mapped by significant region |
TTK |
TTK protein kinase |
6q13-q21 |
Mapped by PBA pathway |
CCND1 |
cyclin D1 |
11q13 |
Mapped by significant region |
SMC1A |
structural maintenance of chromosomes 1A |
Xp11.22-p11.21 |
Mapped by PBA pathway |
ATM |
ataxia telangiectasia mutated |
11q22-q23 |
Mapped by CNV; Mapped by significant region |
SMC3 |
structural maintenance of chromosomes 3 |
10q25 |
Mapped by PBA pathway |
CDC25B |
cell division cycle 25 homolog B (S. pombe) |
20p13 |
Mapped by CNV |
YWHAH |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
22q12.1-q13.1 |
Mapped by PBA pathway |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
9q22.1-q22.2 |
Mapped by significant region |
CDC45 |
cell division cycle 45 homolog (S. cerevisiae) |
22q11.21 |
Mapped by CNV |
PTTG1 |
pituitary tumor-transforming 1 |
5q35.1 |
Mapped by significant region |